A citation-based method for searching scientific literature

Scott A Tomlins, Daniel R Rhodes, Sven Perner, Saravana M Dhanasekaran, Rohit Mehra, Xiao-Wei Sun, Sooryanarayana Varambally, Xuhong Cao, Joelle Tchinda, Rainer Kuefer, Charles Lee, James E Montie, Rajal B Shah, Kenneth J Pienta, Mark A Rubin, Arul M Chinnaiyan. Science 2005
Times Cited: 2770







List of co-cited articles
765 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Integrative clinical genomics of advanced prostate cancer.
Dan Robinson, Eliezer M Van Allen, Yi-Mi Wu, Nikolaus Schultz, Robert J Lonigro, Juan-Miguel Mosquera, Bruce Montgomery, Mary-Ellen Taplin, Colin C Pritchard, Gerhardt Attard,[...]. Cell 2015
16

Integrative genomic profiling of human prostate cancer.
Barry S Taylor, Nikolaus Schultz, Haley Hieronymus, Anuradha Gopalan, Yonghong Xiao, Brett S Carver, Vivek K Arora, Poorvi Kaushik, Ethan Cerami, Boris Reva,[...]. Cancer Cell 2010
15

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.
Christopher E Barbieri, Sylvan C Baca, Michael S Lawrence, Francesca Demichelis, Mirjam Blattner, Jean-Philippe Theurillat, Thomas A White, Petar Stojanov, Eliezer Van Allen, Nicolas Stransky,[...]. Nat Genet 2012
13

Punctuated evolution of prostate cancer genomes.
Sylvan C Baca, Davide Prandi, Michael S Lawrence, Juan Miguel Mosquera, Alessandro Romanel, Yotam Drier, Kyung Park, Naoki Kitabayashi, Theresa Y MacDonald, Mahmoud Ghandi,[...]. Cell 2013
773
13

An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression.
Jindan Yu, Jianjun Yu, Ram-Shankar Mani, Qi Cao, Chad J Brenner, Xuhong Cao, Xiaoju Wang, Longtao Wu, James Li, Ming Hu,[...]. Cancer Cell 2010
599
13

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
12

The mutational landscape of lethal castration-resistant prostate cancer.
Catherine S Grasso, Yi-Mi Wu, Dan R Robinson, Xuhong Cao, Saravana M Dhanasekaran, Amjad P Khan, Michael J Quist, Xiaojun Jing, Robert J Lonigro, J Chad Brenner,[...]. Nature 2012
11

Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer.
Chunru Lin, Liuqing Yang, Bogdan Tanasa, Kasey Hutt, Bong-gun Ju, Kenny Ohgi, Jie Zhang, David W Rose, Xiang-Dong Fu, Christopher K Glass,[...]. Cell 2009
432
10

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S Schiergens, Georg Herrler, Nai-Huei Wu, Andreas Nitsche,[...]. Cell 2020
10

Role of the TMPRSS2-ERG gene fusion in prostate cancer.
Scott A Tomlins, Bharathi Laxman, Sooryanarayana Varambally, Xuhong Cao, Jindan Yu, Beth E Helgeson, Qi Cao, John R Prensner, Mark A Rubin, Rajal B Shah,[...]. Neoplasia 2008
485
9

Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.
Scott A Tomlins, John R Day, Robert J Lonigro, Daniel H Hovelson, Javed Siddiqui, L Priya Kunju, Rodney L Dunn, Sarah Meyer, Petrea Hodge, Jack Groskopf,[...]. Eur Urol 2016
222
8

ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss.
Yu Chen, Ping Chi, Shira Rockowitz, Phillip J Iaquinta, Tambudzai Shamu, Shipra Shukla, Dong Gao, Inna Sirota, Brett S Carver, John Wongvipat,[...]. Nat Med 2013
191
8

Induced chromosomal proximity and gene fusions in prostate cancer.
Ram-Shankar Mani, Scott A Tomlins, Kaitlin Callahan, Aparna Ghosh, Mukesh K Nyati, Sooryanarayana Varambally, Nallasivam Palanisamy, Arul M Chinnaiyan. Science 2009
289
8

Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements.
Michael C Haffner, Martin J Aryee, Antoun Toubaji, David M Esopi, Roula Albadine, Bora Gurel, William B Isaacs, G Steven Bova, Wennuan Liu, Jianfeng Xu,[...]. Nat Genet 2010
411
8

The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis.
Jared M Lucas, Cynthia Heinlein, Tom Kim, Susana A Hernandez, Muzdah S Malik, Lawrence D True, Colm Morrissey, Eva Corey, Bruce Montgomery, Elahe Mostaghel,[...]. Cancer Discov 2014
234
8

Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate.
Brett S Carver, Jennifer Tran, Anuradha Gopalan, Zhenbang Chen, Safa Shaikh, Arkaitz Carracedo, Andrea Alimonti, Caterina Nardella, Shohreh Varmeh, Peter T Scardino,[...]. Nat Genet 2009
478
8

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
8

Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.
Himisha Beltran, Davide Prandi, Juan Miguel Mosquera, Matteo Benelli, Loredana Puca, Joanna Cyrta, Clarisse Marotz, Eugenia Giannopoulou, Balabhadrapatruni V S K Chakravarthi, Sooryanarayana Varambally,[...]. Nat Med 2016
751
7

Genomic hallmarks of localized, non-indolent prostate cancer.
Michael Fraser, Veronica Y Sabelnykova, Takafumi N Yamaguchi, Lawrence E Heisler, Julie Livingstone, Vincent Huang, Yu-Jia Shiah, Fouad Yousif, Xihui Lin, Andre P Masella,[...]. Nature 2017
307
7

STAR: ultrafast universal RNA-seq aligner.
Alexander Dobin, Carrie A Davis, Felix Schlesinger, Jorg Drenkow, Chris Zaleski, Sonali Jha, Philippe Batut, Mark Chaisson, Thomas R Gingeras. Bioinformatics 2013
7

Increased survival with enzalutamide in prostate cancer after chemotherapy.
Howard I Scher, Karim Fizazi, Fred Saad, Mary-Ellen Taplin, Cora N Sternberg, Kurt Miller, Ronald de Wit, Peter Mulders, Kim N Chi, Neal D Shore,[...]. N Engl J Med 2012
7

The genomic complexity of primary human prostate cancer.
Michael F Berger, Michael S Lawrence, Francesca Demichelis, Yotam Drier, Kristian Cibulskis, Andrey Y Sivachenko, Andrea Sboner, Raquel Esgueva, Dorothee Pflueger, Carrie Sougnez,[...]. Nature 2011
892
7

Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
Scott A Tomlins, Bharathi Laxman, Saravana M Dhanasekaran, Beth E Helgeson, Xuhong Cao, David S Morris, Anjana Menon, Xiaojun Jing, Qi Cao, Bo Han,[...]. Nature 2007
593
7

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
7

Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis.
Jennifer C King, Jin Xu, John Wongvipat, Haley Hieronymus, Brett S Carver, David H Leung, Barry S Taylor, Chris Sander, Robert D Cardiff, Suzana S Couto,[...]. Nat Genet 2009
348
7

The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis.
Mark M Pomerantz, Fugen Li, David Y Takeda, Romina Lenci, Apurva Chonkar, Matthew Chabot, Paloma Cejas, Francisca Vazquez, Jennifer Cook, Ramesh A Shivdasani,[...]. Nat Genet 2015
200
6

Topological domains in mammalian genomes identified by analysis of chromatin interactions.
Jesse R Dixon, Siddarth Selvaraj, Feng Yue, Audrey Kim, Yan Li, Yin Shen, Ming Hu, Jun S Liu, Bing Ren. Nature 2012
6

TMPRSS2-ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer.
Ken J Kron, Alexander Murison, Stanley Zhou, Vincent Huang, Takafumi N Yamaguchi, Yu-Jia Shiah, Michael Fraser, Theodorus van der Kwast, Paul C Boutros, Robert G Bristow,[...]. Nat Genet 2017
96
6

Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.
Leander Van Neste, Rianne J Hendriks, Siebren Dijkstra, Geert Trooskens, Erik B Cornel, Sander A Jannink, Hans de Jong, Daphne Hessels, Frank P Smit, Willem J G Melchers,[...]. Eur Urol 2016
195
6

Identification of multipotent luminal progenitor cells in human prostate organoid cultures.
Wouter R Karthaus, Phillip J Iaquinta, Jarno Drost, Ana Gracanin, Ruben van Boxtel, John Wongvipat, Catherine M Dowling, Dong Gao, Harry Begthel, Norman Sachs,[...]. Cell 2014
388
6

Single luminal epithelial progenitors can generate prostate organoids in culture.
Chee Wai Chua, Maho Shibata, Ming Lei, Roxanne Toivanen, LaMont J Barlow, Sarah K Bergren, Ketan K Badani, James M McKiernan, Mitchell C Benson, Hanina Hibshoosh,[...]. Nat Cell Biol 2014
195
6

Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer.
Ian D Davis, Andrew J Martin, Martin R Stockler, Stephen Begbie, Kim N Chi, Simon Chowdhury, Xanthi Coskinas, Mark Frydenberg, Wendy E Hague, Lisa G Horvath,[...]. N Engl J Med 2019
464
6


Recurrent gene fusions in prostate cancer.
Chandan Kumar-Sinha, Scott A Tomlins, Arul M Chinnaiyan. Nat Rev Cancer 2008
508
6

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
Nicholas D James, Johann S de Bono, Melissa R Spears, Noel W Clarke, Malcolm D Mason, David P Dearnaley, Alastair W S Ritchie, Claire L Amos, Clare Gilson, Rob J Jones,[...]. N Engl J Med 2017
842
6

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.
Manabu Soda, Young Lim Choi, Munehiro Enomoto, Shuji Takada, Yoshihiro Yamashita, Shunpei Ishikawa, Shin-ichiro Fujiwara, Hideki Watanabe, Kentaro Kurashina, Hisashi Hatanaka,[...]. Nature 2007
6

Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer.
Irfan A Asangani, Vijaya L Dommeti, Xiaoju Wang, Rohit Malik, Marcin Cieslik, Rendong Yang, June Escara-Wilke, Kari Wilder-Romans, Sudheer Dhanireddy, Carl Engelke,[...]. Nature 2014
602
6

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer.
Karim Fizazi, NamPhuong Tran, Luis Fein, Nobuaki Matsubara, Alfredo Rodriguez-Antolin, Boris Y Alekseev, Mustafa Özgüroğlu, Dingwei Ye, Susan Feyerabend, Andrew Protheroe,[...]. N Engl J Med 2017
992
6

The landscape and therapeutic relevance of cancer-associated transcript fusions.
K Yoshihara, Q Wang, W Torres-Garcia, S Zheng, R Vegesna, H Kim, R G W Verhaak. Oncogene 2015
285
6

TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer.
Scott A Tomlins, Rohit Mehra, Daniel R Rhodes, Lisa R Smith, Diane Roulston, Beth E Helgeson, Xuhong Cao, John T Wei, Mark A Rubin, Rajal B Shah,[...]. Cancer Res 2006
342
6

A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy.
James McKiernan, Michael J Donovan, Vince O'Neill, Stefan Bentink, Mikkel Noerholm, Susan Belzer, Johan Skog, Michael W Kattan, Alan Partin, Gerald Andriole,[...]. JAMA Oncol 2016
294
5

Three-dimensional disorganization of the cancer genome occurs coincident with long-range genetic and epigenetic alterations.
Phillippa C Taberlay, Joanna Achinger-Kawecka, Aaron T L Lun, Fabian A Buske, Kenneth Sabir, Cathryn M Gould, Elena Zotenko, Saul A Bert, Katherine A Giles, Denis C Bauer,[...]. Genome Res 2016
150
5

c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene Networks.
Stefan J Barfeld, Alfonso Urbanucci, Harri M Itkonen, Ladan Fazli, Jessica L Hicks, Bernd Thiede, Paul S Rennie, Srinivasan Yegnasubramanian, Angelo M DeMarzo, Ian G Mills. EBioMedicine 2017
56
8

Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer.
Joachim Weischenfeldt, Ronald Simon, Lars Feuerbach, Karin Schlangen, Dieter Weichenhan, Sarah Minner, Daniela Wuttig, Hans-Jörg Warnatz, Henning Stehr, Tobias Rausch,[...]. Cancer Cell 2013
242
5

Organoid cultures derived from patients with advanced prostate cancer.
Dong Gao, Ian Vela, Andrea Sboner, Phillip J Iaquinta, Wouter R Karthaus, Anuradha Gopalan, Catherine Dowling, Jackline N Wanjala, Eva A Undvall, Vivek K Arora,[...]. Cell 2014
763
5

Cistrome Partitioning Reveals Convergence of Somatic Mutations and Risk Variants on Master Transcription Regulators in Primary Prostate Tumors.
Parisa Mazrooei, Ken J Kron, Yanyun Zhu, Stanley Zhou, Giacomo Grillo, Tahmid Mehdi, Musaddeque Ahmed, Tesa M Severson, Paul Guilhamon, Nicholas Sinnott Armstrong,[...]. Cancer Cell 2019
21
23

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.
F Demichelis, K Fall, S Perner, O Andrén, F Schmidt, S R Setlur, Y Hoshida, J-M Mosquera, Y Pawitan, C Lee,[...]. Oncogene 2007
473
5

Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.
J Chad Brenner, Bushra Ateeq, Yong Li, Anastasia K Yocum, Qi Cao, Irfan A Asangani, Sonam Patel, Xiaoju Wang, Hallie Liang, Jindan Yu,[...]. Cancer Cell 2011
313
5

AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.
Emmanuel S Antonarakis, Changxue Lu, Hao Wang, Brandon Luber, Mary Nakazawa, Jeffrey C Roeser, Yan Chen, Tabrez A Mohammad, Yidong Chen, Helen L Fedor,[...]. N Engl J Med 2014
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.